eznews.in
A new study published in *PLOS Medicine* has revealed that certain combinations of food additives may significantly increase the risk of developing type 2 diabetes. Researchers analyzed data from nearly 109,000 adults in France and identified two specific mixtures of additives linked to heightened diabetes risk, including artificial sweeteners like aspartame and sucralose, emulsifiers, and acid regulators such as citric acid. The study underscores the potential dangers of consuming ultra-processed foods, which often contain multiple additives. Lead author Mathilde Touvier emphasized the need for reevaluating food additive regulations to enhance consumer protection. Experts, including Dr. Mir Ali and dietitian Monique Richard, highlighted the importance of reducing processed food intake and opting for whole foods to mitigate health risks. The findings suggest that awareness of food additives could play a crucial role in diabetes prevention, aligning with public health recommendations to limit non-essential additives in diets. 
Published:
Apr 09 2025, 8 pmeznews.inA recent large-scale study presented at the Nutrition 2025 conference suggests that a diet rich in phytosterols—plant compounds that inhibit cholesterol absorption—may significantly lower the risk of developing type 2 diabetes and heart disease. Analyzing data from over 200,000 U.S. adults, researchers found that individuals with high phytosterol intake were 9% less likely to develop heart disease and 8% less likely to develop diabetes compared to those with lower intake. The study highlights the potential of a plant-based diet in combating these prevalent conditions, particularly as type 2 diabetes rates continue to rise globally. Experts emphasize the need for further research to validate these findings and understand the mechanisms involved, including the role of the gut microbiome. While phytosterols are found in various plant foods, achieving the recommended daily intake through diet alone can be challenging, and supplementation may be necessary for those with elevated cholesterol levels.
Published:
Jun 10 2025, 5 pmeznews.inA recent study presented at the Nutrition 2025 conference indicates that adopting the MIND diet can lower the risk of developing dementia, including Alzheimer's disease, even if started later in life. The MIND diet, developed by researchers at Rush University Medical Center in 2015, emphasizes brain-healthy foods and has been linked to reduced cognitive decline. The study analyzed dietary data from nearly 93,000 U.S. adults aged 45 to 75, revealing that participants who adhered closely to the MIND diet had a 9% lower risk of dementia, with this figure rising to 13% among African American, Latino, and white participants. Notably, those who improved their MIND diet adherence over ten years saw a 25% reduction in risk. The findings underscore the importance of dietary patterns in mid to late life for dementia prevention, suggesting it is never too late to adopt healthier eating habits.
Published:
Jun 10 2025, 12 ameznews.inRecent claims by U.S. Federal Health Secretary Robert F. Kennedy Jr. have sparked debate over the rising prevalence of autism, which he described as an "epidemic" during a press conference. Citing a new CDC report indicating that one in 36 children in the U.S. is diagnosed with autism—up from one in 44 in 2021—Kennedy attributed this increase to environmental toxins. However, a fact-check by Medical News Today, featuring insights from Dr. David Cutler, a family medicine physician, suggests that the rise in diagnoses is largely due to improved awareness, expanded diagnostic criteria, and enhanced screening practices rather than a true increase in prevalence. Factors such as earlier diagnosis, increased advocacy, and diagnostic substitution have contributed to more individuals, including historically underdiagnosed groups, receiving appropriate diagnoses. While environmental factors may play a role, genetic influences remain significant in understanding autism's complexities.
Published:
Jun 09 2025, 8 pmeznews.inA recent study published in the *Journal of the American Nutrition Association* has revealed that consuming two servings of mangoes daily may enhance heart health in postmenopausal women by lowering blood pressure and “bad” cholesterol levels. Conducted by researchers at the University of California, Davis, the study involved 24 overweight or obese women aged 50 to 70, who consumed approximately 1.5 cups of mangoes each day over two weeks. Results indicated a significant reduction in systolic blood pressure and LDL cholesterol levels, alongside a more stable blood sugar response compared to white bread. Lead researcher Robert M. Hackman emphasized the potential of mangoes, rich in nutrients and bioactive compounds, to support cardiovascular health during this critical life stage. Experts highlight the need for further studies to confirm these findings and explore the broader implications for dietary strategies in managing cardiometabolic risks associated with menopause.
Published:
Jun 08 2025, 9 pmeznews.inA recent study conducted by researchers in Toronto has revealed that low-calorie diets may adversely affect mental health, particularly among men. Analyzing data from over 28,500 adults, the study found that participants who restricted their calorie intake exhibited higher depressive symptoms, with those on calorie-restricted diets scoring an average of 0.29 points higher on the Patient Health Questionnaire-9 (PHQ-9) compared to non-dieters. The link was especially pronounced in overweight individuals, with those on nutrient-restricted diets showing a 0.61-point increase in PHQ-9 scores. Experts suggest that extreme dieting can lead to nutritional deficiencies that impact mood regulation. Dietitian Amy Roethler emphasized the importance of balanced nutrition over mere calorie restriction for mental well-being, advocating for registered dietitian support for individuals with a history of depression. The study highlights the need for further research into the mental health consequences of dietary restrictions and associated nutritional deficits.
Published:
Jun 07 2025, 11 ameznews.inA groundbreaking study led by Dr. Erin Mauney is exploring the potential of psilocybin, the active compound in magic mushrooms, as a treatment for irritable bowel syndrome (IBS), a condition that affects millions yet remains poorly understood and often resistant to traditional therapies. The research investigates the gut-brain connection, suggesting that psychological factors, including early-life trauma, may contribute to IBS symptoms. Dr. Mauney's study is the first to examine the effects of psilocybin in conjunction with psychotherapy on IBS patients who have not responded to conventional treatments. Initial results indicate that some participants have experienced symptom relief, with psilocybin potentially enhancing therapeutic processes and alleviating visceral hypersensitivity. While optimism surrounds the findings, experts caution that psilocybin may not work for everyone, underscoring the need for further research into this innovative approach to gut health.
Published:
Jun 06 2025, 10 pmeznews.inA recent study presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting suggests that combining immunotherapy with chemotherapy may significantly improve outcomes for patients with stage 3 deficient mismatch repair (dMMR) colon cancer. This type of cancer, which affects 5-15% of colorectal cancer cases, is often less responsive to traditional chemotherapy. The trial involved 712 participants, averaging 64 years old, who had undergone surgery but still had cancer cells in their lymph nodes. Results indicated a 50% reduction in recurrence and death rates among those receiving the combination treatment, compared to chemotherapy alone. Lead author Dr. Frank Sinicrope emphasized the potential to change treatment paradigms, while other experts highlighted the need for further research to explore long-term effects and integrate these findings into standard care practices. The study, pending peer review, marks a promising advancement in colon cancer treatment.
Published:
Jun 05 2025, 9 pmeznews.inA new study suggests that lemborexant, a medication commonly prescribed for insomnia, may not only enhance sleep quality but also protect against Alzheimer's-related brain damage. Conducted at Washington University School of Medicine, researchers found that this dual orexin receptor antagonist helps prevent the accumulation of tau protein, which is linked to neurodegeneration and cognitive decline in Alzheimer’s patients. The study, published in *Nature Neuroscience*, involved genetically modified mice predisposed to tau buildup. Results indicated that those treated with lemborexant exhibited a 30-40% larger hippocampus, a sign of reduced brain damage. Experts note that poor sleep is often an early indicator of dementia. While the findings are promising, researchers emphasize the need for clinical trials to assess the safety and efficacy of lemborexant in humans, as nearly 40% of Americans suffer from insomnia, which can lead to various cognitive impairments.
Published:
Jun 04 2025, 9 pmeznews.inA recent study led by Canadian researchers suggests that structured exercise programs may significantly reduce the risk of colon cancer recurrence, potentially offering benefits comparable to drug treatments. The research, which involved 889 patients who underwent surgery and chemotherapy for stage 2 or 3 colon cancer, found that those participating in a supervised exercise regimen had a 28% lower risk of cancer recurrence and a 37% lower risk of death from any cause compared to those receiving standard health advice. Notably, 80.3% of the exercise group remained disease-free after five years, compared to 73.9% in the health-education group. Experts highlighted the appeal of exercise as a low-cost intervention with minimal side effects, urging healthcare providers to integrate physical activity into treatment plans. However, challenges remain in implementing such programs widely, emphasizing the need for tailored support to encourage regular exercise among cancer patients.
Published:
Jun 04 2025, 10 pmeznews.inA recent study presented at the Nutrition 2025 conference indicates that daily consumption of chickpeas and black beans may significantly improve health outcomes for individuals with prediabetes. Over 12 weeks, participants who consumed these legumes showed reduced inflammation and lower cholesterol levels compared to those eating white rice. Specifically, chickpea intake was linked to decreased total cholesterol, while black bean consumption lowered inflammatory markers. Although the study involved a small sample size of 72 participants and has yet to undergo peer review, researchers emphasize the potential benefits of legumes, which are affordable and nutritious. With diabetes affecting one in ten Americans, dietary interventions like incorporating beans could be crucial in managing prediabetes, a condition that can be reversed. Experts advocate for increasing legume consumption as part of a balanced diet to support overall health and reduce chronic disease risks.
Published:
Jun 03 2025, 9 pmFor the fastest, latest, not so wokest news, 'experts say' you need to visit Eznews
India
World
Economy
Science
Health
Showbiz
Contact